Adiponectin has been found at lower blood levels in patients with metabolic syndrome (MetS) and its related co-morbidities, including obesity, type 2 diabetes mellitus (DM), dyslipidemia and hypertension [1-4]. This evidence concerns the gene ADIPOQ and obesity disorder.